SOD2 and melanoma: In contrast, Schadendorf showed that serum SOD2 level was elevated in melanoma patients and, since it was correlated to the disease progression, they proposed SOD2 as a tumor marker and a sensitive biomarker in serum for monitoring melanoma [61].